RSM logo
JRSM

Home Current issue Browse archive Alerts About the journal Feedback
 
J R Soc Med 2001;94:265-269
© 2001 Royal Society of Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Send a Quick Comment
Right arrow Alert me when this article is cited
Right arrow Alert me when Quick Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schrier, R. W
Right arrow Articles by Ohara, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Water retention and aquaporins in heart failure, liver disease and pregnancy

Robert W Schrier MD   Melissa A Cadnapaphornchai   Mamiko Ohara

Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado, USA



View larger version (21K):

[in a new window]
 
Figure 1. Backward and forward theories of heart failure [Modified by permission, from Peters JP, Am J Med 1952;12:66]

 


View larger version (15K):

[in a new window]
 
Figure 2. Underfill and overfill hypotheses of oedema formation in cirrhosis [Modified by permission, from Schrier RW, J R Coll Physicians 1992;26:295]

 


View larger version (20K):

[in a new window]
 
Figure 3. Underfill and overfill hypotheses of oedema formation in pregnancy

 


View larger version (21K):

[in a new window]
 
Figure 4. Sequence of events in which a decrease in cardiac output initiates water retention [Modified by permission, from Schrier RW, Ann Intern Med 1990;113:155]

 


View larger version (18K):

[in a new window]
 
Figure 5. Sequence of events in which peripheral arterial vasodilation initiates water retention [Modified by permission, from Schrier RW, J Am Soc Nephrol 1992;2:1549]

 


View larger version (14K):

[in a new window]
 
Figure 6. Effect of VPA-985 administration on urinary AQP2 excretion of heart failure patients according to dose groups. (X axis represents the collection periods. Day - 1 is the baseline observation and day + 1 is the study period. {blacksquare} Baseline; {circ} Placebo; [UNK] 30 mg; {triangleup} 75 mg; {square} 150 mg; {diamondsuit} 250 mg) [Reprinted by permission, from Ref. 20]

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



MDU Exam Doctor